| Patents for C07D 491 - Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups , , or (29,726) |
|---|
| 07/03/2013 | EP2609100A2 Furopyridine derivatives |
| 07/03/2013 | EP2609081A1 Sulfonylpiperazine derivatives that interact with glucokinase regulatory protein for the treatment of diabetes |
| 07/03/2013 | CN103189469A Novel organic electroluminescent compounds and organic electroluminescent device using the same |
| 07/03/2013 | CN103183681A New crystal form of ixabepilone, and preparation method thereof |
| 07/03/2013 | CN103183680A Method for preparing asenapine |
| 07/03/2013 | CN101952259B Benzodiazepine compound and pharmaceutical composition |
| 07/03/2013 | CN101772503B Oxaspirocyclic spiro-substituted tetramic and tetronic acid derivatives |
| 07/02/2013 | US8476439 Pyridine classical cannabinoid compounds and related methods of use |
| 07/02/2013 | CA2687608C Substituted hydroxyethyl amine compounds as beta-secretase modulators and methods of use |
| 07/02/2013 | CA2684599C Crystalline forms of topotecan hydrochloride and processes for making the same |
| 06/27/2013 | WO2013096226A1 Trpv1 antagonists |
| 06/27/2013 | WO2013096223A1 Trpv1 antagonists |
| 06/27/2013 | WO2013094581A1 Novel camptothecin derivative |
| 06/27/2013 | WO2013092941A1 BENZYL SULFONAMIDE DERIVATIVES AS RORc MODULATORS |
| 06/27/2013 | WO2013092790A1 Radiofluorination method |
| 06/27/2013 | WO2013091096A1 Condensed triclyclic compounds as inhibitors of hiv replication |
| 06/27/2013 | WO2013091011A1 Heterocyclic urea compounds |
| 06/27/2013 | WO2013038200A3 Neurodevelopmental disorders |
| 06/27/2013 | US20130165450 Novel Thiazol-Carboximide Derivatives as PDK1 Inhibitors |
| 06/27/2013 | US20130164803 Cyclopropenones and the photochemical generation of cyclic alkynes therefrom |
| 06/26/2013 | EP2607357A1 Benzothiazoles as ghrelin receptor modulators |
| 06/26/2013 | EP2607351A1 Continuous process for the alkylation of cyclic tertiary amines |
| 06/26/2013 | CN103180312A Heterocyclic compounds for treating or preventing disorders caused by reduced neurotransmission of serotonin, norephnephrine or dopamine |
| 06/26/2013 | CN103180310A Hetero-bicyclic derivatives as hcv inhibitors |
| 06/26/2013 | CN103180307A Novel microbicides |
| 06/26/2013 | CN103180272A Methods for ultrasonication-assisted chlorination of aromatic compounds |
| 06/26/2013 | CN103172643A Carbazole alkaloids of clausena lansium and preparation method thereof and medical composition and use thereof |
| 06/26/2013 | CN103172642A Reagent and application thereof in detection of bivalent copper ions |
| 06/26/2013 | CN103172641A Heterocyclic amino and alkoxy-replaced quinazoline derivative and application thereof |
| 06/26/2013 | CN103172575A Preparation method of one-class 1,3-dipole quinazoline compound |
| 06/25/2013 | US8471025 Crystalline forms of trans-7-oxo-6-(sulphooxy)-1,6-diazabicyclo[3,2,1]octane-2-carboxamide sodium salt |
| 06/25/2013 | US8471024 Tetrahydrofuropyridones |
| 06/25/2013 | US8471008 Material for organic electroluminescent element and organic electroluminescent element employing the same |
| 06/25/2013 | US8470875 Use of parthenolide derivatives as antileukemic and cytotoxic agents |
| 06/25/2013 | US8470828 Anellated pyridine compounds |
| 06/25/2013 | CA2724774C Pyrazolospiroketone acetyl-coa carboxylase inhibitors |
| 06/25/2013 | CA2595290C Diazabenzo[de]anthracen-3-one compounds and methods for inhibiting parp |
| 06/25/2013 | CA2551611C Thiazole derivatives for treating or preventing parkinson's disease |
| 06/25/2013 | CA2285241C Substituted 3-cyano quinolines |
| 06/20/2013 | WO2013087591A1 Solid forms of (1r,4r)-6'-fluoro-(n,n-dimethyl)-4-phenyl-4',9'-dihydro-3'h-spiro-[cyclohexane-1,1'-pyrano-[3,4,b]indol]-4-amine and sulfuric acid |
| 06/20/2013 | WO2013087590A1 Solid forms of (1r,4r)-6'-fluoro-n,n-dimethyl-4-phenyl-4',9'-dihydro-3'h-spiro-[cyclohexane-1,1'-pyrano[3,4,b]indol]-4-amine hydrochloride |
| 06/20/2013 | WO2013087589A1 Process for the preparation of (1r,4r)-6'-fluoro-(n,n-dimethyl- and n-methyl)-4-phenyl-4',9'-dihydro-3'h-spiro[cyclohexane-1,1'-pyrano-[3,4,b]indol]-4-amine |
| 06/20/2013 | WO2013087581A1 Amino-substituted imidazopyridazines |
| 06/20/2013 | WO2013020164A9 Compounds for treating respiratory syncytial virus infections |
| 06/20/2013 | US20130158248 Maleimide-furanyl compounds that can be used in a general method for preparing maleimide-oligonucleotide derivatives |
| 06/20/2013 | US20130158067 TRPV1 Antagonists |
| 06/20/2013 | US20130158052 Pyrimidine classical cannabinoid compounds and related methods of use |
| 06/20/2013 | US20130158024 Tricyclic necrostatin compounds |
| 06/20/2013 | US20130158002 Positive allosteric modulators of mglur2 |
| 06/20/2013 | US20130156756 Substituted Triazolopyridines |
| 06/20/2013 | US20130156732 Antiviral compounds |
| 06/19/2013 | EP2604697A1 Triprenyl phenol compounds, process for their production and use as thrombolysis enhancer |
| 06/19/2013 | EP2604597A1 Heterocyclic compound and use thereof |
| 06/19/2013 | CN103159774A Extraction, separation and purification method for strychnos total alkaloid |
| 06/19/2013 | CN103159773A Polycyclic derivative with chiral spirolactone pyrrole ring structural fragment and synthetic method thereof |
| 06/19/2013 | CN103159772A Preparation and application of fluorescein lactam nitric oxide fluorescent probe |
| 06/19/2013 | CN102199154B Novel synthesis method for pyrrole derivatives |
| 06/19/2013 | CN101910179B Glucocorticoid receptor modulator and use method |
| 06/19/2013 | CN101880276B Substituted diazepan compounds as orexin receptor antagonists |
| 06/18/2013 | US8466296 Compounds and processes for preparing substituted aminomethyl-2,3,8,9-tetrahydro-7H-1,4-dioxino[2,3-e]indol-8-ones |
| 06/18/2013 | US8466287 Process for producing tricyclic ketone |
| 06/18/2013 | US8466283 Substituted 2,3-dihydroimidazo[1,2-c]quinazoline derivatives useful for treating hyper-proliferative disorders and diseases associated with angiogenesis |
| 06/18/2013 | US8466168 Tricyclic alkylaminomethyloxazolidinone derivatives |
| 06/18/2013 | US8466142 Cephalotaxus esters, methods of synthesis, and uses thereof |
| 06/18/2013 | US8466115 Spirocyclic isoxazoline derivatives as antiparasitic agents |
| 06/18/2013 | CA2566898C Tri- and bi-cyclic heteroaryl histamine-3 receptor ligands |
| 06/13/2013 | WO2013086200A1 Composition and method for neuropeptide s receptor (npsr) antagonists |
| 06/13/2013 | WO2013085937A1 Process for the production of seven-membered lactam morphinans |
| 06/13/2013 | WO2013085018A1 Phenylpyrrole derivative |
| 06/13/2013 | WO2013084138A1 Cyclic urea derivatives as androgen receptor antagonists |
| 06/13/2013 | WO2013083775A1 New compounds, pharmaceutical compositions and uses thereof |
| 06/13/2013 | WO2013083591A1 Substituted pyrazoles as mglu5 receptor modulators |
| 06/13/2013 | WO2013083216A1 Spiro dihydroacridine derivatives and the use thereof as materials for organic electroluminescence devices |
| 06/13/2013 | WO2013083070A1 1, 4-dihydro-naphthyridine derivative and pharmaceutical composition and use thereof |
| 06/13/2013 | US20130150590 Process for the preparation of (1r,4r)-6'-fluoro-(N,N-dimethyl- and N-methyl)-4-phenyl-4',9'-dihydro-3'H-spiro[cyclohexane-1,1'-pyrano-[3,4,b]indol]-4-amine |
| 06/13/2013 | US20130150589 Solid forms of (1 r,4r)-6' -fluoro-(N, N-dimethyl)-4-phenyl-4' ,9'-dihydro-3'H-spiro[ cyclohexane-1,1 '-pyrano-[3,4,b]indol]-4-amine and sulfuric acid |
| 06/13/2013 | US20130150420 Solid forms of (1r,4r)-6'-fluoro-N,N-dimethyl-4-phenyl-4',9'-dihydro-3' H-spiro-[cyclohexane-1,1'-pyrano-[3,4,b]indol]-4-amine hydrochloride |
| 06/13/2013 | US20130150401 New compounds, pharmaceutical compositions and uses thereof |
| 06/13/2013 | US20130150354 New selective ccr2 antagonists |
| 06/13/2013 | US20130150345 Furo[3, 2-b] pyrr0l-3-ones as cathespin s inhibitors |
| 06/13/2013 | US20130150332 9-aminonoscapine and its use in treating cancers, including drug-resistant cancers |
| 06/13/2013 | CA2858571A1 Composition and method for neuropeptide s receptor (npsr) antagonists |
| 06/13/2013 | CA2858342A1 Phenylpyrrole derivative |
| 06/12/2013 | EP2601197A1 Amino-iso-indole, amino-aza-iso-indole, amino-dihydroisoquinoline and amino-benzoxazine compounds as beta-secretase modulators and methods of use |
| 06/12/2013 | CN103153984A Inhibitors of bruton's tyrosine kinase |
| 06/12/2013 | CN103145720A Preparation method of 10-hydroxycamptothecin monohydrate |
| 06/12/2013 | CN103145719A Preparation method of prodigiosin derivative |
| 06/12/2013 | CN103145702A Aminopyrimidines useful as kinase inhibitors |
| 06/12/2013 | CN101605794B Aza-benzofuranyl compounds and methods of use |
| 06/12/2013 | CN101479274B Pharmaceutical compounds |
| 06/11/2013 | US8461181 Fused heterocyclic compound and use thereof |
| 06/11/2013 | CA2585112C Fused pyrimidines and their use as inhibitors of pi3k |
| 06/06/2013 | WO2013081416A1 Novel organic electroluminescent compounds and organic electroluminescent device using the same |
| 06/06/2013 | WO2013081315A1 Compound for organic electronic device, organic electronic device comprising same and electronic device comprising the organic electronic device |
| 06/06/2013 | WO2013080069A1 Process for the preparation of asenapine intermediate |
| 06/06/2013 | WO2013079494A1 2-phenylaminopyrimidine derivatives as kinase lrrk2 modulators for the treatment of parkinson's disease |
| 06/06/2013 | WO2013079452A1 New bicyclic dihydroisoquinoline-1-one derivatives |
| 06/06/2013 | WO2013043744A3 Tricyclic compounds useful as neurogenic and neuroprotective agents |
| 06/06/2013 | US20130144053 Process for the Production of Seven-Membered Lactam Morphinans |
| 06/06/2013 | CA2850700A1 New bicyclic dihydroisoquinoline-1-one derivatives |